Inmagene’s anti-OX40 mAb demonstrated an extended half-life and a favorable safety profile in a Phase I study
Article Date
August 18, 2023
This article is featured on another website.
Go to article
April 23, 2026
CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New
HiRO Attending CRM Trial Connect 2026 in Kuala Lumpur HiRO will be attending CRM Trial…
April 23, 2026
CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New
HiRO Attending CRM Trial Connect 2026 in Kuala Lumpur HiRO will be attending CRM Trial…
May 12, 2026
HiRO Is Attending DIA China 2026: Meet Us in Shanghai
Visit HiRO at Booth TF01 to discuss Modern, Disciplined CRO Solutions HiRO is excited to…
May 12, 2026
HiRO Is Attending DIA China 2026: Meet Us in Shanghai
Visit HiRO at Booth TF01 to discuss Modern, Disciplined CRO Solutions HiRO is excited to…